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Introduction
The field of in vitro point-of-care (PoC) diagnostic tests has rapidly grown during the past decade. It promises robust systems capable of delivering precise and rapid results about the condition of an individual, which can lead to an improved quality of healthcare at a reduced cost. Urine, blood, and oral or nasal swabs have been extensively investigated as diagnostic samples in the healthcare setting. Here we present a detection method aimed at diagnosis using breath sampling.
Much effort has been made in the past to link volatile organic compounds (VOCs) in exhaled air, to a patient's state of health [1] , specifically with respect to identifying biomarkers for cancer [2] [3] [4] [5] [6] . Exhaled breath contains both gases, and aerosol droplets, however, the main focus of breath analysis thus far, has been on gas detection, which can contain: inorganic gases, i.e. NO [7] CO [8] ; hydrocarbons, i.e. isoprene [9] ethane or pentane [10] ; and volatile and non-volatile substances, such as isoprostane, cytokines, leukotrienes [11] , proteins, nucleic acids, or polypeptides [12, 13] , bacteria or viruses. VOCs appear in gaseous form in breath, typically analysed using ion mobility spectroscopy, chromatographic, or mass spectroscopic techniques, which are reviewed by Buszewski et al. [14] . However, non-volatile substances in breath are transported via aerosol droplets, such as the Torque Teno virus [15] , or Influenza [16] . These aerosolized droplets, are thought to be generated from the lung lining fluid via film rupturing following contraction of the bronchioles [17] [18] [19] . There has been a lot of emphasis on detection of VOCs using gas analysis or condensates [20] [21] [22] , however few studies have been aimed at the capture detection of microorganisms in exhaled breath. Specifically, aerosols with droplet size >1 µm are formed through coughing [23] [24] [25] [26] [27] and are targeted in our work.
Integrating a capture system for these aerosol droplets in a PoC device could form a completely noninvasive alternative to traditional lung sampling methods, such as the very invasive and uncomfortable bronchoscopy procedure. Nonetheless, there are difficulties that are inherent to sampling breath including: variances in aerosol droplet size, number concentration, composition, and low concentration of analytes present in the sample [24, 25, [28] [29] [30] [31] . Such a complex and diverse aerosol is difficult to simulate in the laboratory, thus a mock breath aerosol of specified composition, droplet size, and concentration is generated and used for characterization. The challenge of the low amount of sample present in breath means it is crucial for a point-of-care test to have both: a high collection efficiency, and the ability to upconcentrate collected samples for very sensitive detection of analytes. There also exists a lack of standard methodology for breath sampling, and appropriate and standardized breathing protocols remain to be established.
Traditionally, sampling of aerosol droplets is achieved using inertial impaction, e.g. using impingers [32] [33] [34] , which was used for comparison in this work, or via direct impaction [35, 36] . In 1955, the use of electrostatic precipitators (ESPs) was introduced as a potential alternative, when Kraemer et al. [37] explained, theoretically, the charging and capture of aerosol droplets in the presence of electrostatic fields. Since then, ESPs have been used extensively by industry, e.g. in air purifiers, but only recently have they been considered as a potential method for the capture of exhaled bioaerosols. Miller et al. [38] demonstrated a hand-held ESP device for breath sampling relying on transmission electron microscopy (TEM) for sample analysis, which is not a suitable detection method for PoC applications. Alternatively, Kettleson et al. [39] demonstrated inactivation of aerosolized viruses using an ESP. Christensen et al. [40] utilized a commercial, chip-based ESP to analyse breath from cattle for detection of foot-and-mouth disease. The drawback with their method is the indirect collection, i.e. not directly from the cattle's mouth but from ambient air in the farmhouse, leading to lower collected amounts of exhaled aerosol when compared with direct breath. Similarly, Han & Mainelis [41] introduced an ESP sampler for bioaerosols, mainly targeting airborne pathogens and microorganisms, by collecting rolling water droplets off the collection electrode. Tan et al. [42] proposed an airborne bacteria sampler using a semi-spherical electrostatic precipitator, and reported varying relative collection efficiencies, ϒ ESPon/ESPoff , from 50% to 100%, where the total capture was compared with that when no voltages were applied to the ESP electrodes. The collection was dependent on applied voltages, flow rates, particle sizes and geometrical design parameters. All the above ESP devices, although successful in capturing their target aerosol, are solely focused on capturing airborne droplets from ambient air, and do not provide the possibility for uncomplicated downstream integration of biosensors with the instrument.
For integration of breath aerosol sampling in a PoC diagnostic device, one of the most challenging aspects is the direct interfacing of breath with a lab-on-a-chip (LoC) cartridge [43] . In particular, a robust air-liquid interface is required to allow capture of the aerosol droplets and dispersion of the captured sample in a liquid medium, in which direct initiation of specific ligand-receptor biochemical reactions can occur. We have previously presented microsystem-based components for air-liquid interfacing in combination with downstream analysis, for quartz crystal microbalance (QCM) sensing of airborne narcotics [44, 45] . Two examples of such surface tension-based air-liquid interfacing include: pillar forests and perforated diaphragms. They allow for use of a liquid flow in the chip while simultaneously offering a large and robust air-liquid interface area. Moreover, a perforated diaphragm allows for placement of a biosensor in close proximity to the air-liquid interface, which potentially simplifies the overall LoC design and reduce the risk for sample-to-channel surface interactions inherent to fluidic transport in microfluidics.
This paper considers an integrated aerosol sampling and analysis system, designed for future use in point-of-care breath based diagnostics. We first introduce the combination of ESP with lab-on-chip technologies, the former for aerosol collection and the latter for integrated sample handling and biomarker detection. The remainder of the paper details the design, governing parameters and experimental investigation of an aerosol-to-chip ESP based sampler. First we review the major physical phenomena involved in electrostatic aerosol capture and investigate the governing geometric and operational parameters using finite elements (FE) simulations. Thereafter we describe the building and experimental testing of the prototype. We used laboratory generated aerosol to derive the prototype characteristics. Sampling efficiencies of the prototype are reported and compared with those of a commercial Biosampler impinger.
PoC concept for integrated aerosol sampling and analysis
The concept of the proposed PoC device arises from the unique combination of two elements: an ESP to capture aerosol droplets, and a microfluidic lab-on-a-chip containing an air-liquid interface and an on-chip biosensor. All of this can potentially be incorporated into one portable instrument with a mouthpiece for sampling patients' breath (Fig. 1) . The aerosol droplets enter the ESP through a mouthpiece, are electrically charged, transported, and captured onto the microfluidic air-liquid interface of the lab-on-a-chip cartridge. In the ESP, a twoelectrode multi-point-to-plane corona discharge cell is used to charge and capture aerosol droplets. Metal needles are used as corona discharge electrodes, and the air-liquid interface constitutes the planar capture electrode. The collected sample can then be subsequently analysed for biomarkers or other biological entities using a relevant assay and on-chip transducer.
Contrary to the analysis of VOCs, which can be performed utilizing optical equipment, the analysis of complex biomolecules such as nucleic acids, proteins or even entire pathogens present in aerosol, requires collection of the dispersed aerosol droplets into a continuous liquid phase suited for subsequent sample preparation and analyte detection. Microfluidic devices are ideal for handling and analysis of such liquid samples [46] and have the advantage of allowing integration with an ESP. A previous preliminary investigation, by Sandström et al. [47] , demonstrated a prototype microfluidic air-liquid interface for integration with ESP ( Fig. 2A) . This air-liquid interface, featuring a perforated Si diaphragm for stabilising the interface position, was combined with a geometrically non-optimized ESP system, and was shown to successfully capture airborne smoke particles to a microfluidic device. Hydrophobic smoke particles were shown to mostly collect on the surface of the air-liquid interface, while hydrophilic smoke particles absorbed into the liquid on-chip. Further, previously unpublished experiments on a similar system demonstrate integration of the smoke capture system with components from a breathing apparatus, see Figure 2B . The ESP system is shown to successfully guide smoke particles through one of the branches of a symmetric Y-shaped junction to a collector chip. Figure 1 Conceptual design of the proposed PoC device using exhaled-breath aerosol as diagnostic sample. A cross-section of the PoC ESP sampler shows needles as corona discharge electrodes, while the lab-on-chip cartridge acts as the collection electrode. Exhaled breath aerosol enters in the centre, and a sheath flow is implemented to increase flow control. The lab-on-chip cartridge includes an air-liquid interface, and a biosensor.
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Design and Modelling of ESP
We built an experimental device to investigate the capture efficiency of aerosol droplets using an ESP integrated with an open air-liquid interface. We optimized the design of this ESP sampler for an efficient and localized aerosol capture. A two-electrode, multi-point-to-plane configuration is used ( Fig. 1) , in which several needles constitute the corona discharge electrodes, and the air-liquid interface, a 10 mm diameter open well, constitutes the collection electrode. To better assess the capture efficiency of the ESP design, we forego the perforated Si diaphragm, to avoid the risk of sample loss due to adsorption of aerosol droplets to the diaphragm. Next we describe the underlying physics, the parameters, and the FE model of the ESP sampler.
Physical Mechanism of ESP
An ESP consists of a discharge and a collection electrode with a voltage difference that results in a strong electric field. This field induces a corona discharge that leads to ionization of the air molecules near the electrode tip. Incoming aerosol droplets collide with the ionized air molecules, thus becoming electrically charged, and are transported by the electrostatic force towards the collector electrode. Aerosol droplets acquire positive charges in a positive corona, and negative charges in a negative corona.
Initiation of a corona depends strongly on the electrode configuration, i.e. point-to-plane, or wire-to- In the left image, both the smoke and the ESP are off. In the center image, the ESP is off and no smoke is generated, exiting through both the left and right outlets. In the right image, the ESP is on and the generated smoke is successfully guided towards the collector chip at the right outlet of the Y-shaped tube.
plane; and the electric potential gradient around the discharge electrode, which is determined by the electrode curvature. Exceedingly high field strength can cause an electrical breakdown of the corona, leading to arcing, and to unwanted production of ozone molecules. Inhalation of ozone, has been linked to reduced lung function [48] and increased susceptibility to respiratory infections [49] therefore limitations to the field strength must be enforced. Aerosol droplets acquire charges by either active field charging or diffusion charging, with both effects often occurring simultaneously but with varying intensity depending on the conditions. Field charging is the active collision of corona-generated ions with an aerosol droplet and is predominantly governed by ion concentration, electric field strength (Equation 1), and time. Diffusion charging is the process by which aerosol droplets acquire charge from random collisions with ions, due to Brownian motion, and is dependent on the number of ions available, as well as the duration of exposure (Equation 2).
Equation (2) where n(t) = number of charges acquired by an aerosol droplet; d p = aerosol droplet diameter; k = Boltzmann's constant; T = temperature; K E = constant of proportionality; e = elementary charge; i = mean thermal speed of ions; N i = concentration of ions; E = electric field; ε = relative permittivity ; t = charging time; Z i = mobility of ions (Hinds, 1999).
After acquiring charges, electrohydrodynamic (EHD) transport of the droplet in the ESP occurs by a combination of diffusion, migration, and convection. More detailed information about the physics of electrostatic precipitators can be found in Hinds' Aerosol Technology (1999).
Geometric and Electrical Parameters
Three types of parameters govern the ESP: electrical parameters, geometrical design, and aerosol characteristics. Firstly, the number of electrodes and their potentials dominate the electrical parameters. Secondly, physical geometrical parameters are governed by:
a. the axial inter-electrode distance, D, i.e. distance between the axial centric of the plane created by the tips of the needles and the plane of the collection vessel b. the number of the coronizing electrodes, three, and their radial position, R n , placed at an angular distribution of 120 deg c. the flow rates, for the supplementary clean air sheath flow which surrounds the aerosol influx, (Fig. 1) . Thirdly, the aerosol characteristics are governed by flow rate, droplet size distribution, and droplet concentration.
Finite elements modelling
The ESP parameters considered are: the axial electrode distance, D, the corona current, I, and the device geometry, i.e. the diameter of the ESP, inlet tube, collector vessel, as well as the radial position of the needles, and their tip radius, R tip . The coronizing electrodes' position and number are chosen to maximize ion generation, whereas the amount of electrodes used was limited to keep the device complexity low. Aerosol characteristics are modelled after the nebuliser used in the experiment. The ESP geometry and operational parameters were first studied using finite element (FE) modelling. The interplay between the electric field, charge transport, and aerosol flow was studied by implementing a model in COMSOL Multiphysics 4.2b. The ESP geometry, shown in Figure 1 , can be simplified for modelling using cylindrical and planar symmetry (Fig. 3E) . A 60° slice of the cylindrical ESP is used during computation. The geometry that is presented here corresponds to that of the experimental prototype, the size ratio between the cylindrical chamber and the aerosol inlet tube was chosen to approach isokinetic conditions for both the sheath and aerosol flows. The outer domain of the ESP was given a dimension of 0.4 m in height and radius for two reasons: to account for the electric field extension outside of the ESP; and for investigating the influence of electrically grounded objects at close distance to the ESP, on the overall electrostatic field distribution.
Physical phenomena addressed in this model include the bi-directional couplings between: the electrostatic potential and the transport of charged species, via the charge density and electric field; the transport of charged species and the fluidic flow, via the charge density and electric force; and unidirectional coupling between: the electrostatic potential and the fluidic flow, via the electric force.
The electrostatic potential and field are described using the Poisson equation; the transport of charged species is described by the Nernst-Plank equations; the fluidic flow is described by the Navier-Stokes equations; and particle tracing is achieved using Newton's second law with drag and electric force using a specific module in the FE software. Part of the model is based on the work of [50, 51] , using the Kaptzov's hypothesis for the corona onset, i.e. with electric field density at the outer ionization zone of the negative corona discharge at a constant value of !""# = 3.6 • 10 ! Vm -1 . The unipolar zone is defined as the region in space where mostly only co-ions, those of same sign as the electrode potential, subsist and travel towards the collection electrode. The radius of the outer ionization zone can be estimated as
Equation (4) As boundary conditions, the electric potential was set at given values, V discharge and V collector , on the corona and collector electrodes, respectively. In previous publications, the electric field at the outer ionization zone was manually iteratively adjusted by adapting the surface charge density, !"# , at the outer ionization zone until the electric field E Peek was obtained, which corresponds to the Kaptzov's hypothesis. Our model features an automatic adjustment of the ion density to respect the following function:
The ion density at the collector electrode was set to zero, assuming no ion accumulation at the surface,
i.e. no limiting current density, which is justified by the very low current induced by the corona discharge and the large electrode surface. The zero ion density condition was also applied at the flow inlets and outlet, which is equivalent to an outlet connected to an infinitely large reservoir free of ions. The other surfaces were insulating. The flow rates, Q sheath flow and Q aerosol flow , were fixed at the sheath flow and aerosol inlets, while non-turbulent flow at atmospheric pressure was imposed at the outlet.
For particle tracing, 50 water droplets of diameters 1 and 2.7 µm, corresponding to the size of droplets generated by the medical nebuliser used in the experimental work, were released at the entrance of the aerosol inlet tube with a uniform distribution. The particle charge, q particle , was approximated to increase linearly with exposure duration and was increased linearly after passing near the corona electrode until reaching a maximum value. The saturation charge value was computed by taking the limit as time approaches infinity, of the equations for field and diffusion charging (Eq. 1 & 2).
The flow profile, electric field lines, and particle flow trajectory were computed for different values of the needle voltage, flow rates, charges, and distances. Some results are presented in Figure 3 , where the electric potential distribution, the anion volume density distribution, the anion flux stream lines, the gas flow and the particle trajectories are shown for D = 3 cm and an electrode potential difference of 6 kV. The total electric current was computed as 1.22 µA. For these conditions and for a particle size of 2.7 µm, 37 out of the 50 particles released were collected; while the remaining particles entered flow vortexes induced by the EHD flow, and did not reach the collector within the computed time. For 1 µm particles, 29 out of 50 were collected. The decrease in capture efficiency with particle size is expected considering the decrease of accumulated charge, electric force, and inertia for decreasing particle size. For increasing values of D, the collection efficiency was considerably decreasing, but limited computing power prevented quantification of the collection efficiency. One must note that it is difficult to obtain exact quantitative data for the aerosol transport through modelling, due to approximations made by setting: the Peek value, the coronizing volume at the needle electrode, and the particle charging. However, the FE model allows us to determine a number of design features and to simulate relevant configurations, from which two main points can be concluded. First, the corona discharge can produce strong EHD jet (wind), depending on the geometrical and electrical configurations. This can cause flow vortexes that severely reduce the particle capture efficiency. The following design features reduce the occurrence of vortices and increase the trapping of aerosol droplets:
i. several corona needle electrodes placed concentrically, instead of one that is centrally positioned ii.
the smallest radial distance of the needles, with respect to the aerosol inlet iii.
an increased sheath flow rate and reduced aerosol flow rate iv.
a distance, D, tuned for optimal electrical charging of the particles, and reduced EHD flow jetting through a lower electric field.
Experimental setup 4.1 Aerosol sampler prototype
The experimental ESP sampler, Figure 4 , consists of a 100 mm diameter polycarbonate cylindrical tube encasing three corona discharge needle electrodes and a collector electrode, with inlets placed on top of the tube for aerosol and sheath flow input and one outlet placed at the bottom. The cylindrical geometry of the ESP was chosen for its axial symmetry, with the aim to allow for smooth and controlled air stream with minimum turbulence to avoid disturbing the aerosol collection. Three, 5 µm tip Tungsten needles (American Probe Inc., USA) optimally positioned, according to the FE simulations, radially at 2 cm from the centre line, and axially aligned such that the needle tips are 1 cm below the aerosol inlet. The collection electrode is a shallow well milled in polycarbonate plastic.
The remaining setup includes the ESP aerosol inlet connected to an Albatross 009H-40-A nebuliser (AIOLOS Medical, Sweden) working at a nebulization rate of 0.8 ml/min and airflow rate of 8 l/m, providing aerosol droplets with a mass median diameter (MMD) of 2.7 µm at a pressure of 2 bar. To prevent contamination of the needles from incoming aerosol droplets, or from stray particles from the outside environment, two sheath flow inlets (connected to Inlet 2 in Figure 4 ) are connected via a HEPA filter (HMEF 750, GE Healthcare, Finland) to a humidifier, ensuring an input of clean, controlled 85% RH air. The ESP outlet is connected to an impinger, SKC BioSampler (SKC Inc. USA), which in turn, is connected to a vacuum pump.
A power supply module, based on the negative C60 component (EMCO High Voltage Corporation, USA), supplied a high potential difference (1 kV to 5.5 kV) over the electrodes. Varying the needle potential between -3 and -5.5 kV provides a tuneable corona current, I, which varies in the range 0-20 µA depending on D. Currents were monitored with a 8Z True RMS multimeter (Fluke Corporation, USA), and a 34401A multimeter (Hewlett Packard, USA).
The Biosampler impinger, a gold standard, operates at a fixed flow rate of 12.5 l/min at a minimum working pressure drop of 0.5 bar as compared with atmospheric pressure. The flow and pressure over the impinger were monitored with a MPX5100D mass flow sensor (Motorola, USA) and a differential pressure sensor, respectively. 
Measurement Protocol
The ESP sampler efficiency and performance were evaluated by measuring the transport of dye solution from the nebuliser to the collector and to the impinger. The evaluation was performed for D = 0, 3, 5, and 7 cm. Experiment preparation included: placing 4 ml of 300 mg/l dye solution Alphazurine A (Sigma-Aldrich, Sweden) dissolved in 0.5 M KCl (Sigma-Aldrich, Sweden), in the nebuliser, 2 ml of 0.5 M KCl in the impinger (SKC BioSampler), and 200 µl of the same 0.5 M KCL solution placed inside the collector. In this study a laboratory-generated aerosolized dye is used to be able to characterise the ESP rather than real breath samples, since it provides a simple method of quantification using absorption of light through the samples. This synthetic dye aerosol is a well-controlled sample, which is ideal for characterising the ESP since it eliminates all the unknowns that are present in a human breath sample.
The ESP cylinder was sealed to create a closed system and the vacuum was turned on. Thereafter, the electrode potential was switched on to induce a corona current, which was measured. Once a stable current was achieved, the nebuliser was switched on for 30 s. Following this, the nebuliser was turned off, while the vacuum and electrode potential conditions were left on for one extra minute to purge the system of any remaining aerosol. Subsequently the liquids from the collector, and the impinger, were extracted by pipetting the volume into an Eppendorf tube, and weighed, in order to calculate their volumes. Optical absorption values of all samples were measured using a Genesys 20 visible spectrophotometer (ThermoScientific, USA) at a path length of 10 mm, and Eppendorf UV-specific cuvettes (VWR, Sweden). The absorption data and corresponding sample volumes allow calculation of the respective molar dye concentrations and the amount of dye particles collected using the Beer-Lambert law.
Additionally, experiments were conducted to quantify the output flow of the nebuliser, as well as the flow split after the T-junction in order to characterise the aerosol input entering the ESP. Nebulisation rate of the AIOLOS was determined by measuring the volume of liquid before and after 4 minutes of nebulisation. The nebulisation rate was found to be 0.256 mL per 30 seconds. An AWM5102VN flow sensor (Honeywell, USA) was used to measure the flow output at the nebuliser to be 7.17 l/min, and the flow at the entrance of the ESP to be 1.36 l/min, 20% of the output flow of the nebuliser. Therefore, assuming the air flow rate is directly related to the number of particles, and at a nebulisation rate of 0.256 ml/30 sec using a dye concentration of 300 mg/l, the total amount of aerosolized dye entering the ESP, n dye input , is calculated to be 21 nmoles for the duration of the experiment.
Experimental Results & Discussion
This section describes and discusses the electrical characteristics and experimental collection efficiency of the ESP sampler for varying inter-electrode distances and corona currents.
The current-voltage relationship of the ESP is plotted in Figure 5 (left) for D = 3, 5 and 7 cm. Similar to findings from Vega (1999) and Gallo (1977) , no corona is produced at an electrode potential difference of < 3 kV. Gallo presents a voltage-current relationship for a point-to-plane configuration for air around atmospheric pressure, which displays a stable quasi-linear region (for 3-7 kV) where a self-sustained corona can be maintained. This is also observed in our ESP, confirming the presence of a corona. Values of corona current for our ESP are lower than the findings from Gallo, since their configuration involved needle-to-plane electrodes with a larger distance between needle and plane electrodes, while ours is a multi-needle-to-plane system with a small inter-electrode distance.
Successful aerosol capture was achieved with the ESP sampler and the absolute collection efficiency is plotted in Figure 5 (right). The efficiency can be calculated as the ratio of dye captured in the collector, to the amount of dye entering the ESP, ϒ absolute = n dye collector /n dye input . A maximum efficiency of > 20 % is achieved for D = 3 cm, and I = 4 µA. For larger inter-electrode distances, decreased collection efficiency was observed, and confirms results from the FE modelling. For shorter distances, i.e. D = 0 cm, a decreased collection efficiency was also observed, which is attributed to shorter charging time and, hence, less-efficient electrophoretic capture.
When the ESP was turned off, meaning no voltage was applied and no corona occurs, the collection efficiency of aerosol droplets was consistently < 1%, confirming the success of electrostatic precipitation as mechanism for aerosol capture.
The absolute losses in the system can be estimated from the consistent collection efficiency of the impinger to be n losses = 1-ϒ impinger = 1-(n dye impinger / n dye input) = 81% of n dye input and are attributed for the most part to the tube bends and junctions.
In comparison with the state-of-the-art Biosampler impinger, the performance of our ESP sampler is on par, with maximum collection efficiencies 21% for our ESP sampler and a consistent efficiency 19% for the impinger. In addition to a comparable efficiency, our ESP sampler has specific advantages over the impinger. The microfluidic interface at the collection site enables integration with lab-on-a-chip technologies, by allowing for robust sample handling and for the possible integration of a biosensor in very close proximity to the interface. The small collection volume used in our ESP sampler, 300 µl, is in stark contrast with the large volume, 4 ml, used in the impinger, and provides collected sample solutions with higher concentrations, at least 10 fold in our experiments, than when sampled using the impinger. Furthermore, the collection volume in the proposed ESP sampler, Fig. 1 , has the potential to be further miniaturized, allowing sample volumes as little as 3.5 µl, as previously shown ). Hence, the concentrated solutions achieved using our ESP sampler potentially allows for highly sensitive and rapid detection of analytes when integrated with a biosensor. Additional advantages of the ESP sampler as a method of aerosol capture include: flow rates of the ESP sampler not being fixed, as with impingers, and can be dictated by the breath patterns of the patient.
In comparison with results from Tan et al. (2011) , the relative collection efficiency of our ESP sampler was consistently ϒ relative = (1-n ESPoff / n ESPon ) ≈ 100%, without the large variations, ϒ relative = 70% -90%, seen from their sampler.
For translating the technology from our lab setting to clinical breath aerosol sampling, the following challenges need addressing. There is a need to further investigate the effect on the sampling efficiency of both the large range of aerosol droplet sizes and number concentration occurring in patient breath samples, and the patient breathing pattern. Also, further research is needed on the integration of downstream sensing of the biomarkers of interest, and the adaptation to the clinical end-user setting in terms of power supply and form factor.
Conclusion
In conclusion, we present a concept device for ESP-based aerosol sampling for the potential capture of human exhaled-breath aerosols, in particular generated by coughing, for PoC diagnostics. This device would directly interface aerosol droplets with a microfluidic lab-on-chip platform by using a microfluidic air-liquid interface. The capture of the aerosol droplets relies on an ESP, using a multi-point-to-plane corona discharge mechanism. To design this system, a finite elements model was implemented for qualitative prediction of the behaviour of aerosol droplets in the ESP sampler. This design was used to build an experimental prototype, which was characterized for its capture efficiency using an aerosolized dye sample simulating breath aerosol. Varying inter-electrode distances and corona currents allowed finding optimal operational parameters, and an open air-liquid microfluidic interface was used, which can be used advantageously towards integration in a point-of-care test. The ESP sampler proved successful in capturing >20% of the total aerosol generated by the nebuliser, and was as efficient as a gold standard aerosol sampler, an impinger, with the additional benefit of providing highly concentrated samples. These advantages make the proposed electrostatic precipitator-based prototype potentially suitable for point-ofcare diagnostics based on human exhaled-breath aerosol.
